Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Expert Review of Hematology
|
July 1, 2024
Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?
Varsha Bhat, Vivien A Sheehan
British Journal of Haematology
|
November 17, 2017
Fetal haemoglobin induction in sickle cell disease
Alireza Paikari, Vivien A Sheehan
Experimental Biology and Medicine (Maywood, N.J.)
|
March 20, 2016
Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease
Carly C Ginter Summarell, Vivien A Sheehan
Current Opinion in Hematology
|
November 22, 2013
Hepatitis C and neutropenia
Vivien A Sheehan, Alva Weir, Bradford Waters
Nature Medicine
|
October 6, 2022
Africa must participate in finding a gene therapy cure for sickle-cell disease
Grace Moshi, Vivien A Sheehan, Julie Makani
JAMA Internal Medicine
|
July 22, 2024
Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes
Ashwin P Patel, Morgan McLemore, Vivien A Sheehan
European Journal of Haematology
|
April 18, 2020
The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management
Deepika S Darbari, Vivien A Sheehan, Samir K Ballas
Journal of Clinical Medicine
|
June 10, 2022
Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease
Lukasz P Gondek, Vivien A Sheehan, Courtney D Fitzhugh
Journal of Pediatric Hematology/Oncology
|
April 24, 2018
A Retrospective Analysis of Sociodemographic and Hematologic Characteristics Associated With Achieving Optimal Hydroxyurea Therapy in Children With Sickle Cell Disease
Paul E George, Juan C Bazo-Alvarez, Vivien A Sheehan
Experimental Biology and Medicine (Maywood, N.J.)
|
January 18, 2020
Blood rheology biomarkers in sickle cell disease
Madeleine Lu, Minke Ae Rab, Sergey S Shevkoplyas, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Expert Review of Hematology
|
July 1, 2024
Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?
Varsha Bhat, Vivien A Sheehan
British Journal of Haematology
|
November 17, 2017
Fetal haemoglobin induction in sickle cell disease
Alireza Paikari, Vivien A Sheehan
Experimental Biology and Medicine (Maywood, N.J.)
|
March 20, 2016
Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease
Carly C Ginter Summarell, Vivien A Sheehan
Current Opinion in Hematology
|
November 22, 2013
Hepatitis C and neutropenia
Vivien A Sheehan, Alva Weir, Bradford Waters
Nature Medicine
|
October 6, 2022
Africa must participate in finding a gene therapy cure for sickle-cell disease
Grace Moshi, Vivien A Sheehan, Julie Makani
JAMA Internal Medicine
|
July 22, 2024
Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes
Ashwin P Patel, Morgan McLemore, Vivien A Sheehan
European Journal of Haematology
|
April 18, 2020
The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management
Deepika S Darbari, Vivien A Sheehan, Samir K Ballas
Journal of Clinical Medicine
|
June 10, 2022
Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease
Lukasz P Gondek, Vivien A Sheehan, Courtney D Fitzhugh
Journal of Pediatric Hematology/Oncology
|
April 24, 2018
A Retrospective Analysis of Sociodemographic and Hematologic Characteristics Associated With Achieving Optimal Hydroxyurea Therapy in Children With Sickle Cell Disease
Paul E George, Juan C Bazo-Alvarez, Vivien A Sheehan
Experimental Biology and Medicine (Maywood, N.J.)
|
January 18, 2020
Blood rheology biomarkers in sickle cell disease
Madeleine Lu, Minke Ae Rab, Sergey S Shevkoplyas, et al.
Page
of 5